Home : FDA Drug Database : Actisite : FDA Information : Prescription and Over-the-Counter Drug Product List: Cumulative Supplement Number 5: May 2007

Prescription and Over-the-Counter Drug Product List: Cumulative Supplement Number 5: May 2007

Prescription and Over-the-Counter Drug Product List
27th Edition
Cumulative Supplement Number 5: May 2007

Prescription     OTC

NOTE: The format for the Monthly Additions/Deletions Drug Product List changed as of the July Cumulative Supplement (CS) of the 21st Edition to mirror the CS. Refer to the CS Preface section 1.6 Cumulative Supplement Legend. PDF

ADDITIONS/DELETIONS FOR PRESCRIPTION DRUG PRODUCT LIST

         ACETAMINOPHEN; HYDROCODONE BITARTRATE          TABLET; ORAL            HYDROCODONE BITARTRATE AND ACETAMINOPHEN>D>   AA      UCB INC                    500MG;10MG                              N40210 001  Aug 13, 1997    May  DISC>A>         @                            500MG;10MG                              N40210 001  Aug 13, 1997    May  DISC>D>   AA                                 650MG;7.5MG                             N40134 001  Nov 21, 1996    May  DISC>A>         @                            650MG;7.5MG                             N40134 001  Nov 21, 1996    May  DISC        ACETAZOLAMIDE          CAPSULE, EXTENDED RELEASE; ORAL            DIAMOX>D>         @ DURAMED PHARMS             500MG                                   N12945 001                  May  CMFD>A>       +                              500MG                                   N12945 001                  May  CMFD        ALBUTEROL SULFATE          SOLUTION; INHALATION            ALBUTEROL SULFATE>D>   AN      ROXANE                     EQ 0.083% BASE                          N75129 001  Feb 13, 2001    May  DISC>A>         @                            EQ 0.083% BASE                          N75129 001  Feb 13, 2001    May  DISC        ALLOPURINOL SODIUM          INJECTABLE; INJECTION            ALOPRIM>A>   AP  +   BIONICHE PHARMA            EQ 500MG BASE/VIAL                      N20298 001  May 17, 1996    May  CAHN>D>   AP  +   NABI                       EQ 500MG BASE/VIAL                      N20298 001  May 17, 1996    May  CAHN        ALPRAZOLAM          TABLET, EXTENDED RELEASE; ORAL            ALPRAZOLAM>A>   AB      IMPAX LABS                 0.5MG                                   N77968 004  May 24, 2007    May  NEWA>A>   AB                                 1MG                                     N77968 003  May 24, 2007    May  NEWA>A>   AB                                 2MG                                     N77968 002  May 24, 2007    May  NEWA>A>   AB                                 3MG                                     N77968 001  May 24, 2007    May  NEWA        AMIODARONE HYDROCHLORIDE          INJECTABLE; INJECTION>D>         CORDARONE>D>   AP  +   WYETH PHARMS               50MG/ML                                 N20377 001  Aug 03, 1995    May  DISC>A>         @                            50MG/ML                                 N20377 001  Aug 03, 1995    May  DISC        AMLODIPINE BESYLATE          TABLET; ORAL            AMLODIPINE BESYLATE>A>   AB      APOTEX                     EQ 2.5MG BASE                           N76719 001  May 23, 2007    May  NEWA>A>   AB                                 EQ 5MG BASE                             N76719 002  May 23, 2007    May  NEWA>A>   AB                                 EQ 10MG BASE                            N76719 003  May 23, 2007    May  NEWA        AMLODIPINE BESYLATE; BENAZEPRIL HYDROCHLORIDE          CAPSULE; ORAL>A>         AMLODIPINE BESYLATE AND BENAZEPRIL HYDROCHLORIDE>A>   AB      TEVA PHARMS                EQ 2.5MG BASE;10MG                      N77179 001  May 18, 2007    May  NEWA>A>   AB                                 EQ 5MG BASE;10MG                        N77179 002  May 18, 2007    May  NEWA>A>   AB                                 EQ 5MG BASE;20MG                        N77179 003  May 18, 2007    May  NEWA>A>   AB                                 EQ 10MG BASE;20MG                       N77179 004  May 18, 2007    May  NEWA            LOTREL>D>           NOVARTIS                   EQ 2.5MG BASE;10MG                      N20364 002  Mar 03, 1995    May  CFTG>A>   AB                                 EQ 2.5MG BASE;10MG                      N20364 002  Mar 03, 1995    May  CFTG>D>                                      EQ 5MG BASE;10MG                        N20364 003  Mar 03, 1995    May  CFTG>A>   AB                                 EQ 5MG BASE;10MG                        N20364 003  Mar 03, 1995    May  CFTG>D>                                      EQ 5MG BASE;20MG                        N20364 004  Mar 03, 1995    May  CFTG>A>   AB                                 EQ 5MG BASE;20MG                        N20364 004  Mar 03, 1995    May  CFTG>D>                                      EQ 10MG BASE;20MG                       N20364 005  Jun 20, 2002    May  CFTG>A>   AB                                 EQ 10MG BASE;20MG                       N20364 005  Jun 20, 2002    May  CFTG        AMOXICILLIN          CAPSULE; ORAL>D>         TRIMOX>D>   AB      APOTHECON                  250MG                                   N61885 001                  May  DISC>A>         @                            250MG                                   N61885 001                  May  DISC>D>   AB                                 500MG                                   N61885 002                  May  DISC>A>         @                            500MG                                   N61885 002                  May  DISC        AZACITIDINE>A>       INJECTABLE; IV-SC>A>         VIDAZA>A>       +   PHARMION                   100MG/VIAL                              N50794 001  May 19, 2004    May  CDFR>D>       INJECTABLE; SUBCUTANEOUS>D>         VIDAZA>D>       +   PHARMION                   100MG/VIAL                              N50794 001  May 19, 2004    May  CDFR        AZITHROMYCIN          INJECTABLE; INJECTION            AZITHROMYCIN>D>   AP  +   SICOR PHARMS               EQ 500MG BASE/VIAL                      N50809 001  Dec 19, 2006    May  CAHN>D>       +                              EQ 2.5GM BASE/VIAL                      N50809 002  Dec 19, 2006    May  CAHN>A>   AP  +   TEVA PARENTERAL            EQ 500MG BASE/VIAL                      N50809 001  Dec 19, 2006    May  CAHN>A>       +                              EQ 2.5GM BASE/VIAL                      N50809 002  Dec 19, 2006    May  CAHN          SOLUTION/DROPS; OPHTHALMIC            AZASITE>D>       +   INSITE VISION              1%                                      N50810 001  Apr 27, 2007    May  CAHN>A>       +   INSPIRE                    1%                                      N50810 001  Apr 27, 2007    May  CAHN          TABLET; ORAL            AZITHROMYCIN>A>   AB      MYLAN                      EQ 250MG BASE                           N65365 001  May 30, 2007    May  NEWA>A>   AB                                 EQ 500MG BASE                           N65366 001  May 30, 2007    May  NEWA        BETAMETHASONE DIPROPIONATE          LOTION, AUGMENTED; TOPICAL>A>         BETAMETHASONE DIPROPIONATE>A>   AB      ALTANA                     EQ 0.05% BASE                           N77111 001  May 21, 2007    May  NEWA>A>   AB      TARO                       EQ 0.05% BASE                           N77477 001  May 21, 2007    May  NEWA            DIPROLENE>D>       +   SCHERING                   EQ 0.05% BASE                           N19716 001  Aug 01, 1988    May  CFTG>A>   AB  +                              EQ 0.05% BASE                           N19716 001  Aug 01, 1988    May  CFTG>D>     BISKALCITRATE; METRONIDAZOLE; TETRACYCLINE>D>       CAPSULE; ORAL>D>         PYLERA>D>       +   AXCAN                      140MG;125MG;125MG                       N50786 001  Sep 28, 2006    May  CAIN>A>     BISMUTH SUBCITRATE POTASSIUM; METRONIDAZOLE; TETRACYCLINE>A>       CAPSULE; ORAL>A>         PYLERA>A>       +   AXCAN                      140MG;125MG;125MG                       N50786 001  Sep 28, 2006    May  CAIN        BUPIVACAINE HYDROCHLORIDE          INJECTABLE; INJECTION            SENSORCAINE>A>   AP      ABRAXIS                    0.25%                                   N70552 001  May 21, 1986    May  CAHN>A>   AP                                 0.25%                                   N18304 001                  May  CAHN>A>   AP                                 0.5%                                    N70553 001  May 21, 1986    May  CAHN>A>   AP                                 0.5%                                    N18304 002                  May  CAHN>A>   AP                                 0.75%                                   N70554 001  May 21, 1986    May  CAHN>A>   AP                                 0.75%                                   N18304 003                  May  CAHN>D>   AP      ASTRAZENECA                0.25%                                   N70552 001  May 21, 1986    May  CAHN>D>   AP                                 0.25%                                   N18304 001                  May  CAHN>D>   AP                                 0.5%                                    N70553 001  May 21, 1986    May  CAHN>D>   AP                                 0.5%                                    N18304 002                  May  CAHN>D>   AP                                 0.75%                                   N70554 001  May 21, 1986    May  CAHN>D>   AP                                 0.75%                                   N18304 003                  May  CAHN          INJECTABLE; SPINAL            SENSORCAINE>A>   AP      ABRAXIS                    0.75%                                   N71202 001  Apr 15, 1987    May  CAHN>D>   AP      ASTRAZENECA                0.75%                                   N71202 001  Apr 15, 1987    May  CAHN        BUPIVACAINE HYDROCHLORIDE; EPINEPHRINE BITARTRATE          INJECTABLE; INJECTION            SENSORCAINE>A>   AP      ABRAXIS                    0.25%;0.0091MG/ML                       N70967 001  Oct 13, 1987    May  CAHN>A>   AP                                 0.25%;0.0091MG/ML                       N70966 001  Oct 13, 1987    May  CAHN>A>   AP                                 0.5%;0.0091MG/ML                        N70968 001  Oct 13, 1987    May  CAHN>A>   AP                                 0.5%;0.0091MG/ML                        N18304 004  Sep 02, 1983    May  CAHN>A>   AP                                 0.75%;0.0091MG/ML                       N18304 005  Sep 02, 1983    May  CAHN>D>   AP      ASTRAZENECA                0.25%;0.0091MG/ML                       N70967 001  Oct 13, 1987    May  CAHN>D>   AP                                 0.25%;0.0091MG/ML                       N70966 001  Oct 13, 1987    May  CAHN>D>   AP                                 0.5%;0.0091MG/ML                        N70968 001  Oct 13, 1987    May  CAHN>D>   AP                                 0.5%;0.0091MG/ML                        N18304 004  Sep 02, 1983    May  CAHN>D>   AP                                 0.75%;0.0091MG/ML                       N18304 005  Sep 02, 1983    May  CAHN        CAFFEINE CITRATE          SOLUTION; INTRAVENOUS            CAFFEINE CITRATE>A>   AP      LUITPOLD                   EQ 30MG BASE/3ML (EQ 10MG               N77906 001  May 15, 2007    May  NEWA        CEFACLOR          CAPSULE; ORAL            CEFACLOR>D>   AB      TEVA                       EQ 250MG BASE                           N64145 001  Jun 24, 1996    May  DISC>A>         @                            EQ 250MG BASE                           N64145 001  Jun 24, 1996    May  DISC>D>   AB                                 EQ 500MG BASE                           N64145 002  Jun 24, 1996    May  DISC>A>         @                            EQ 500MG BASE                           N64145 002  Jun 24, 1996    May  DISC        CEFADROXIL/CEFADROXIL HEMIHYDRATE          CAPSULE; ORAL            CEFADROXIL>D>   AB      AUROBINDO                  500MG                                   N65352 001  Jan 25, 2007    May  CPOT>A>   AB                                 EQ 500MG BASE                           N65352 001  Jan 25, 2007    May  CPOT>A>   AB      LUPIN                      EQ 500MG BASE                           N65392 001  May 29, 2007    May  NEWA        CEFAZOLIN SODIUM          INJECTABLE; INJECTION            CEFAZOLIN SODIUM>A>   AP      SANDOZ                     EQ 1GM BASE/VIAL                        N65345 001  May 09, 2007    May  NEWA        CEFDINIR          CAPSULE; ORAL            CEFDINIR>A>   AB      TEVA PHARMS                300MG                                   N65368 001  May 09, 2007    May  NEWA        CEFPROZIL          TABLET; ORAL            CEFPROZIL>A>   AB      AUROBINDO                  250MG                                   N65340 001  May 24, 2007    May  NEWA>A>   AB                                 500MG                                   N65340 002  May 24, 2007    May  NEWA        CEPHALEXIN          FOR SUSPENSION; ORAL            CEPHALEXIN>D>       +   CEPH INTL                  EQ 100MG BASE/ML                        N62117 001                  May  DISC>A>         @                            EQ 100MG BASE/ML                        N62117 001                  May  DISC>D>   AB      TEVA                       EQ 125MG BASE/5ML                       N62767 001  Jun 16, 1987    May  DISC>A>         @                            EQ 125MG BASE/5ML                       N62767 001  Jun 16, 1987    May  DISC>D>   AB                                 EQ 250MG BASE/5ML                       N62768 001  Jun 16, 1987    May  DISC>A>         @                            EQ 250MG BASE/5ML                       N62768 001  Jun 16, 1987    May  DISC>D>     CEPHRADINE>D>       CAPSULE; ORAL>D>         CEPHRADINE>D>           TEVA                       250MG                                   N62683 001  Jan 09, 1987    May  DISC>A>         @                            250MG                                   N62683 001  Jan 09, 1987    May  DISC>D>       +                              500MG                                   N62683 002  Jan 09, 1987    May  DISC>A>         @                            500MG                                   N62683 002  Jan 09, 1987    May  DISC>D>       FOR SUSPENSION; ORAL>D>         ANSPOR>D>   AB      GLAXOSMITHKLINE            125MG/5ML                               N61866 001                  May  DISC>A>         @                            125MG/5ML                               N61866 001                  May  DISC>D>   AB                                 250MG/5ML                               N61866 002                  May  DISC>A>         @                            250MG/5ML                               N61866 002                  May  DISC>D>         CEPHRADINE>D>   AB      TEVA                       125MG/5ML                               N62693 001  Jan 09, 1987    May  DISC>A>         @                            125MG/5ML                               N62693 001  Jan 09, 1987    May  DISC>D>   AB                                 250MG/5ML                               N62693 002  Jan 09, 1987    May  DISC>A>         @                            250MG/5ML                               N62693 002  Jan 09, 1987    May  DISC>D>         VELOSEF '125'>D>   AB  +   APOTHECON                  125MG/5ML                               N61763 001                  May  DISC>A>         @                            125MG/5ML                               N61763 001                  May  DISC>D>         VELOSEF '250'>D>   AB  +   APOTHECON                  250MG/5ML                               N61763 002                  May  DISC>A>         @                            250MG/5ML                               N61763 002                  May  DISC        CITALOPRAM HYDROBROMIDE          TABLET; ORAL            CITALOPRAM HYDROBROMIDE>D>   AB      ROXANE                     EQ 10MG BASE                            N77041 001  Nov 23, 2004    May  DISC>A>         @                            EQ 10MG BASE                            N77041 001  Nov 23, 2004    May  DISC>D>   AB                                 EQ 20MG BASE                            N77041 002  Nov 23, 2004    May  DISC>A>         @                            EQ 20MG BASE                            N77041 002  Nov 23, 2004    May  DISC        CLINDAMYCIN PHOSPHATE          INJECTABLE; INJECTION            CLINDAMYCIN PHOSPHATE>A>   AP      ABRAXIS PHARM              EQ 150MG BASE/ML                        N65347 001  May 09, 2007    May  NEWA        CLOCORTOLONE PIVALATE          CREAM; TOPICAL            CLODERM>A>       +   CORIA                      0.1%                                    N17765 001                  May  CAHN>D>       +   HEALTHPOINT                0.1%                                    N17765 001                  May  CAHN        CLOZAPINE          TABLET, ORALLY DISINTEGRATING; ORAL            FAZACLO ODT>A>           AVANIR PHARMS              12.5MG                                  N21590 004  May 30, 2007    May  NEWA        CROMOLYN SODIUM          SOLUTION; INHALATION            CROMOLYN SODIUM>D>   AN      ROXANE                     10MG/ML                                 N75175 001  Sep 30, 1999    May  DISC>A>         @                            10MG/ML                                 N75175 001  Sep 30, 1999    May  DISC        DALTEPARIN SODIUM>D>       INJECTABLE; INJECTION>D>         FRAGMIN>D>       +   PHARMACIA AND              2,500 IU/0.2ML                          N20287 001  Dec 22, 1994    May  CDFR>D>       +                              5,000 IU/0.2ML                          N20287 003  Mar 18, 1996    May  CDFR>D>       +                              7,500 IU/0.3ML                          N20287 005  Apr 04, 2002    May  CDFR>D>       +                              10,000 IU/ML                            N20287 004  Jan 30, 1998    May  CDFR>D>       +                              95,000IU/3.8ML(25,000IU/ML)             N20287 006  Apr 04, 2002    May  CDFR>D>       +                              95,000IU/9.5ML(10,000IU/ML)             N20287 007  Apr 04, 2002    May  CDFR>A>       INJECTABLE; SUBCUTANEOUS>A>         FRAGMIN>A>       +   PHARMACIA AND              2,500IU/0.2ML (12,500IU/ML)             N20287 001  Dec 22, 1994    May  CDFR>A>       +                              5,000IU/0.2ML (25,000IU/ML)             N20287 003  Mar 18, 1996    May  CDFR>A>       +                              7,500IU/0.3ML (25,000IU/ML)             N20287 005  Apr 04, 2002    May  CDFR>A>       +                              10,000IU/0.4ML (25,000IU/ML)            N20287 002  May 01, 2007    May  NEWA>A>       +                              10,000IU/ML (10,000IU/ML)               N20287 004  Jan 30, 1998    May  CDFR>A>       +                              12,500IU/0.5ML (25,000IU/ML)            N20287 009  May 01, 2007    May  NEWA>A>       +                              15,000IU/0.6ML (25,000IU/ML)            N20287 010  May 01, 2007    May  NEWA>A>       +                              18,000IU/0.72ML (25,000IU/ML)           N20287 011  May 01, 2007    May  NEWA>A>       +                              95,000IU/3.8ML(25,000IU/ML)             N20287 006  Apr 04, 2002    May  CDFR>A>       +                              95,000IU/9.5ML(10,000IU/ML)             N20287 007  Apr 04, 2002    May  CDFR        DAPSONE          GEL; TOPICAL            ACZONE>A>         @ QLT USA                    5%                                      N21794 001  Jul 07, 2005    May  CAHN>D>         @ TOLMAR                     5%                                      N21794 001  Jul 07, 2005    May  CAHN        DEFEROXAMINE MESYLATE          INJECTABLE; INJECTION            DEFEROXAMINE MESYLATE>A>   AP      BEDFORD                    500MG/VIAL                              N78086 001  May 30, 2007    May  NEWA>A>   AP                                 2GM/VIAL                                N78086 002  May 30, 2007    May  NEWA        DESONIDE          CREAM; TOPICAL>A>         DESONIDE>A>   AB  +   PERRIGO NEW YORK           0.05%                                   N17010 001                  May  CTNA>D>         TRIDESILON>D>   AB  +   PERRIGO NEW YORK           0.05%                                   N17010 001                  May  CTNA          OINTMENT; TOPICAL>A>         DESONIDE>A>   AB  +   PERRIGO NEW YORK           0.05%                                   N17426 001                  May  CTNA>D>         TRIDESILON>D>   AB  +   PERRIGO NEW YORK           0.05%                                   N17426 001                  May  CTNA        DIAZOXIDE          SUSPENSION; ORAL            PROGLYCEM>D>       +   BAKER NORTON               50MG/ML                                 N17453 001                  May  CAHN>A>       +   IVAX RES                   50MG/ML                                 N17453 001                  May  CAHN        DIFLORASONE DIACETATE          OINTMENT; TOPICAL>D>         FLORONE>D>         @ PHARMACIA AND              0.05%                                   N17994 001                  May  CTNA>A>         PSORCON E>A>         @ PHARMACIA AND              0.05%                                   N17994 001                  May  CTNA        ECONAZOLE NITRATE          CREAM; TOPICAL            ECONAZOLE NITRATE>D>   AB      HEALTHPOINT                1%                                      N76574 001  Dec 17, 2004    May  CAHN>A>   AB      PRASCO                     1%                                      N76574 001  Dec 17, 2004    May  CAHN        ENALAPRILAT          INJECTABLE; INJECTION            VASOTEC>D>         @ BIOVAIL LABS INTL          1.25MG/ML                               N19309 001  Feb 09, 1988    May  CMFD>A>   AP  +                              1.25MG/ML                               N19309 001  Feb 09, 1988    May  CMFD        ERYTHROMYCIN          OINTMENT; TOPICAL            AKNE-MYCIN>A>       +   CORIA                      2%                                      N50584 001  Jan 10, 1985    May  CAHN>D>       +   HEALTHPOINT                2%                                      N50584 001  Jan 10, 1985    May  CAHN          SWAB; TOPICAL>D>         C-SOLVE-2>D>   AT      IVAX PHARMS                2%                                      N62751 001  Jul 30, 1993    May  DISC>A>         @                            2%                                      N62751 001  Jul 30, 1993    May  DISC>D>         ERYCETTE>D>   AT  +   J AND J                    2%                                      N50594 001  Feb 15, 1985    May  DISC>A>         @                            2%                                      N50594 001  Feb 15, 1985    May  DISC            ERYTHROMYCIN>D>   AT      ALTANA                     2%                                      N65320 001  Jul 25, 2006    May  CRLD>A>   AT  +                              2%                                      N65320 001  Jul 25, 2006    May  CRLD>D>   AT      STIEFEL                    2%                                      N64128 001  Jul 03, 1996    May  DISC>A>         @                            2%                                      N64128 001  Jul 03, 1996    May  DISC>D>   AT                                 2%                                      N64126 001  Jul 03, 1996    May  CRLD>A>   AT  +                              2%                                      N64126 001  Jul 03, 1996    May  CRLD        ESTAZOLAM          TABLET; ORAL            ESTAZOLAM>D>   AB      TEVA                       2MG                                     N74921 002  Jul 10, 1997    May  CRLD>A>   AB  +                              2MG                                     N74921 002  Jul 10, 1997    May  CRLD        ETHINYL ESTRADIOL; LEVONORGESTREL          TABLET; ORAL>A>         LYBREL>A>       +   WYETH PHARMS               0.02MG;0.09MG                           N21864 001  May 22, 2007    May  NEWA        FLUOXETINE HYDROCHLORIDE          CAPSULE; ORAL            FLUOXETINE>A>   AB      MYLAN                      EQ 40MG BASE                            N75207 003  May 25, 2007    May  NEWA>A>     FORMOTEROL FUMARATE>A>       SOLUTION; INHALATION>A>         PERFOROMIST>A>       +   DEY LP                     0.02MG/2ML                              N22007 001  May 11, 2007    May  NEWA        GABAPENTIN          CAPSULE; ORAL            GABAPENTIN>A>   AB      WATSON LABS                100MG                                   N75485 003  May 11, 2007    May  NEWA>A>   AB                                 300MG                                   N75485 002  May 11, 2007    May  NEWA>A>   AB                                 400MG                                   N75485 001  May 11, 2007    May  NEWA        GEMFIBROZIL          TABLET; ORAL            GEMFIBROZIL>A>   AB      IMPAX PHARMS               600MG                                   N78207 001  Jun 01, 2007    May  NEWA        HISTRELIN ACETATE          IMPLANT; SUBCUTANEOUS>A>         SUPPRELIN LA>A>       +   INDEVUS                    50MG                                    N22058 001  May 03, 2007    May  NEWA        HYDROCORTISONE BUTYRATE>A>       LOTION; TOPICAL>A>         LOCOID>A>       +   FERNDALE LABS              0.1%                                    N22076 001  May 18, 2007    May  NEWA        IDARUBICIN HYDROCHLORIDE          INJECTABLE; INJECTION            IDARUBICIN HYDROCHLORIDE>A>   AP      BEDFORD LABS               1MG/ML                                  N65288 001  May 15, 2007    May  NEWA        INDIUM IN-111 CHLORIDE          INJECTABLE; INJECTION            INDICLOR>D>       +   AMERSHAM                   2mCi/0.2ML                              N19862 001  Dec 29, 1992    May  CAHN>A>       +   GE HEALTHCARE              2mCi/0.2ML                              N19862 001  Dec 29, 1992    May  CAHN        INSULIN GLULISINE RECOMBINANT>A>       INJECTABLE; IV (INFUSION)-SC>A>         APIDRA>A>       +   SANOFI AVENTIS US          1000 UNITS/10ML (100 UNITS/ML)          N21629 001  Apr 16, 2004    May  CDFR>A>       +                              300 UNITS/3ML (100 UNITS/ML)            N21629 002  Dec 20, 2005    May  CDFR>D>       INJECTABLE; SUBCUTANEOUS>D>         APIDRA>D>       +   SANOFI AVENTIS US          1000 UNITS/10ML (100 UNITS/ML)          N21629 001  Apr 16, 2004    May  CDFR>D>       +                              300 UNITS/3ML (100 UNITS/ML)            N21629 002  Dec 20, 2005    May  CDFR        LEUCOVORIN CALCIUM          INJECTABLE; INJECTION            LEUCOVORIN CALCIUM>D>   AP      PHARMACHEMIE               EQ 350MG BASE/VIAL                      N40262 001  Dec 15, 1999    May  DISC>A>         @                            EQ 350MG BASE/VIAL                      N40262 001  Dec 15, 1999    May  DISC>D>   AP      PHARMACHEMIE USA           EQ 50MG BASE/VIAL                       N89628 001  Apr 17, 1997    May  DISC>A>         @                            EQ 50MG BASE/VIAL                       N89628 001  Apr 17, 1997    May  DISC>A>     LEVOCETIRIZINE DIHYDROCHLORIDE>A>       TABLET; ORAL>A>         XYZAL>A>       +   UCB INC                    5MG                                     N22064 001  May 25, 2007    May  NEWA        LISDEXAMFETAMINE DIMESYLATE          CAPSULE; ORAL            VYVANSE>D>           NEW RIVER                  30MG                                    N21977 001  Feb 23, 2007    May  CAHN>D>                                      50MG                                    N21977 002  Feb 23, 2007    May  CAHN>D>       +                              70MG                                    N21977 003  Feb 23, 2007    May  CAHN>A>           NEW RIVER                  30MG                                    N21977 001  Feb 23, 2007    May  CAHN>A>                                      50MG                                    N21977 002  Feb 23, 2007    May  CAHN>A>       +                              70MG                                    N21977 003  Feb 23, 2007    May  CAHN        MAFENIDE ACETATE          CREAM; TOPICAL            SULFAMYLON>D>       +   MYLAN BERTEK               EQ 85MG BASE/GM                         N16763 001                  May  CAHN>A>       +   UDL LABS                   EQ 85MG BASE/GM                         N16763 001                  May  CAHN          FOR SOLUTION; TOPICAL            SULFAMYLON>D>       +   MYLAN BERTEK               5%                                      N19832 003  Jun 05, 1998    May  CAHN>A>       +   UDL LABS                   5%                                      N19832 003  Jun 05, 1998    May  CAHN        MEPIVACAINE HYDROCHLORIDE          INJECTABLE; INJECTION            POLOCAINE>A>   AP      ABRAXIS                    1%                                      N89407 001  Dec 01, 1986    May  CAHN>A>   AP                                 2%                                      N89410 001  Dec 01, 1986    May  CAHN>D>   AP      ASTRAZENECA                1%                                      N89407 001  Dec 01, 1986    May  CAHN>D>   AP                                 2%                                      N89410 001  Dec 01, 1986    May  CAHN            POLOCAINE-MPF>A>   AP      ABRAXIS                    1%                                      N89406 001  Dec 01, 1986    May  CAHN>A>   AP                                 1.5%                                    N89408 001  Dec 01, 1986    May  CAHN>A>   AP                                 2%                                      N89409 001  Dec 01, 1986    May  CAHN>D>   AP      ASTRAZENECA                1%                                      N89406 001  Dec 01, 1986    May  CAHN>D>   AP                                 1.5%                                    N89408 001  Dec 01, 1986    May  CAHN>D>   AP                                 2%                                      N89409 001  Dec 01, 1986    May  CAHN>A>     MERCAPTOPURINE>A>       TABLET; ORAL>A>         MERCAPTOPURINE>A>   AB      MYLAN                      50MG                                    N40594 001  Jul 01, 2005    May  CAIN>D>     MERCAPTOPURINE ANHYDROUS>D>       TABLET; ORAL>D>         MERCAPTOPURINE>D>   AB      MYLAN                      50MG                                    N40594 001  Jul 01, 2005    May  CAIN>A>     METFORMIN HYDROCHLORIDE; PIOGLITAZONE HYDROCHLORIDE>A>       TABLET; ORAL>A>         ACTOPLUS MET>A>           TAKEDA GLOBAL              500MG;EQ 15MG BASE                      N21842 001  Aug 29, 2005    May  CAIN>A>       +                              850MG;EQ 15MG BASE                      N21842 002  Aug 29, 2005    May  CAIN>D>     METFORMIN; PIOGLITAZONE HYDROCHLORIDE>D>       TABLET; ORAL>D>         ACTOPLUS MET>D>           TAKEDA GLOBAL              500MG;EQ 15MG BASE                      N21842 001  Aug 29, 2005    May  CAIN>D>       +                              850MG;EQ 15MG BASE                      N21842 002  Aug 29, 2005    May  CAIN        METHADONE HYDROCHLORIDE          TABLET; ORAL            METHADONE HYDROCHLORIDE>D>   AA      ROXANE                     5MG                                     N88108 001  Mar 08, 1983    May  DISC>A>         @                            5MG                                     N88108 001  Mar 08, 1983    May  DISC>D>   AA                                 10MG                                    N88109 001  Mar 08, 1983    May  DISC>A>         @                            10MG                                    N88109 001  Mar 08, 1983    May  DISC>D>   AA                                 40MG                                    N74081 001  Apr 28, 1995    May  DISC>A>         @                            40MG                                    N74081 001  Apr 28, 1995    May  DISC        METHYLPHENIDATE HYDROCHLORIDE          CAPSULE, EXTENDED RELEASE; ORAL            METADATE CD>D>   BX  +   UCB INC                    30MG                                    N21259 002  Jun 19, 2003    May  CRLD>A>   BX                                 30MG                                    N21259 002  Jun 19, 2003    May  CRLD        METOLAZONE          TABLET; ORAL            METOLAZONE>D>   AB      ROXANE                     10MG                                    N76482 002  Apr 29, 2004    May  DISC>A>         @                            10MG                                    N76482 002  Apr 29, 2004    May  DISC        METOPROLOL SUCCINATE          TABLET, EXTENDED RELEASE; ORAL            METOPROLOL SUCCINATE>A>   AB      KV PHARM                   EQ 100MG TARTRATE                       N76640 002  May 18, 2007    May  NEWA>A>   AB                                 EQ 200MG TARTRATE                       N76640 001  May 18, 2007    May  NEWA>A>   AB      SANDOZ                     EQ 50MG TARTRATE                        N76969 002  May 18, 2007    May  NEWA            TOPROL-XL>D>       +   ASTRAZENECA                EQ 50MG TARTRATE                        N19962 001  Jan 10, 1992    May  CFTG>A>   AB  +                              EQ 50MG TARTRATE                        N19962 001  Jan 10, 1992    May  CFTG>D>                                      EQ 100MG TARTRATE                       N19962 002  Jan 10, 1992    May  CFTG>A>   AB                                 EQ 100MG TARTRATE                       N19962 002  Jan 10, 1992    May  CFTG>D>       +                              EQ 200MG TARTRATE                       N19962 003  Jan 10, 1992    May  CFTG>A>   AB  +                              EQ 200MG TARTRATE                       N19962 003  Jan 10, 1992    May  CFTG        METOPROLOL TARTRATE          INJECTABLE; INJECTION            METOPROLOL TARTRATE>A>   AP      HIKMA                      1MG/ML                                  N77761 001  May 30, 2007    May  NEWA        MORPHINE SULFATE          INJECTABLE; INJECTION            ASTRAMORPH PF>A>   AP      ABRAXIS                    0.5MG/ML                                N71051 001  Oct 07, 1986    May  CAHN>A>   AP                                 0.5MG/ML                                N71050 001  Oct 07, 1986    May  CAHN>A>   AP                                 1MG/ML                                  N71053 001  Oct 07, 1986    May  CAHN>A>   AP                                 1MG/ML                                  N71052 001  Oct 07, 1986    May  CAHN>D>   AP      ASTRAZENECA                0.5MG/ML                                N71051 001  Oct 07, 1986    May  CAHN>D>   AP                                 0.5MG/ML                                N71050 001  Oct 07, 1986    May  CAHN>D>   AP                                 1MG/ML                                  N71053 001  Oct 07, 1986    May  CAHN>D>   AP                                 1MG/ML                                  N71052 001  Oct 07, 1986    May  CAHN        OXYBUTYNIN CHLORIDE          TABLET, EXTENDED RELEASE; ORAL            OXYBUTYNIN CHLORIDE>A>   AB      IMPAX PHARMS               5MG                                     N76745 002  May 09, 2007    May  NEWA>A>   AB                                 10MG                                    N76745 003  May 09, 2007    May  NEWA>A>   AB      MYLAN                      15MG                                    N78293 001  May 10, 2007    May  NEWA        OXYCODONE HYDROCHLORIDE          TABLET, EXTENDED RELEASE; ORAL            OXYCONTIN>D>           PURDUE PHARMA LP           15MG                                    N20553 006  Sep 18, 2006    May  DISC>A>         @                            15MG                                    N20553 006  Sep 18, 2006    May  DISC>D>                                      30MG                                    N20553 007  Sep 18, 2006    May  DISC>A>         @                            30MG                                    N20553 007  Sep 18, 2006    May  DISC>D>                                      60MG                                    N20553 008  Sep 18, 2006    May  DISC>A>         @                            60MG                                    N20553 008  Sep 18, 2006    May  DISC        POLYETHYLENE GLYCOL 3350          FOR SOLUTION; ORAL            POLYETHYLENE GLYCOL 3350>D>   AA      COASTAL PHARMS             17GM/SCOOPFUL                           N77893 001  May 26, 2006    May  CAHN>A>   AA      PADDOCK                    17GM/SCOOPFUL                           N77893 001  May 26, 2006    May  CAHN        POLYETHYLENE GLYCOL 3350; POTASSIUM CHLORIDE; SODIUM BICARBONATE; SODIUM          FOR SUSPENSION; ORAL            GO-EVAC>A>   AA      BOCA PHARMA                236GM/BOT;2.97GM/BOT;6.74GM/BOT;        N73433 001  Apr 28, 1992    May  CAHN>D>   AA      COPLEY PHARM               236GM/BOT;2.97GM/BOT;6.74GM/BOT;        N73433 001  Apr 28, 1992    May  CAHN        PRAVASTATIN SODIUM          TABLET; ORAL            PRAVASTATIN SODIUM>A>   AB      GLENMARK                   10MG                                    N77987 001  May 11, 2007    May  NEWA>A>   AB                                 20MG                                    N77987 002  May 11, 2007    May  NEWA>A>   AB                                 40MG                                    N77987 003  May 11, 2007    May  NEWA        PROPRANOLOL HYDROCHLORIDE>D>       CONCENTRATE; ORAL>D>         PROPRANOLOL HYDROCHLORIDE INTENSOL>D>       +   ROXANE                     80MG/ML                                 N71388 001  May 15, 1987    May  DISC>A>         @                            80MG/ML                                 N71388 001  May 15, 1987    May  DISC        QUETIAPINE FUMARATE>A>       TABLET, EXTENDED RELEASE; ORAL>A>         SEROQUEL XR>A>           ASTRAZENECA                50MG                                    N22047 001  May 17, 2007    May  NEWA>A>                                      200MG                                   N22047 002  May 17, 2007    May  NEWA>A>                                      300MG                                   N22047 003  May 17, 2007    May  NEWA>A>       +                              400MG                                   N22047 004  May 17, 2007    May  NEWA>A>     ROTIGOTINE>A>       FILM, EXTENDED RELEASE; TRANSDERMAL>A>         NEUPRO>A>           SCHWARZ                    2MG/24HR                                N21829 001  May 09, 2007    May  NEWA>A>                                      4MG/24HR                                N21829 002  May 09, 2007    May  NEWA>A>       +                              6MG/24HR                                N21829 003  May 09, 2007    May  NEWA        SIMVASTATIN          TABLET; ORAL            SIMVASTATIN>A>   AB      LUPIN                      10MG                                    N78103 001  May 11, 2007    May  NEWA>A>   AB                                 20MG                                    N78103 002  May 11, 2007    May  NEWA>A>   AB                                 40MG                                    N78103 003  May 11, 2007    May  NEWA>A>   AB                                 80MG                                    N78103 004  May 11, 2007    May  NEWA        TAMOXIFEN CITRATE          TABLET; ORAL            TAMOXIFEN CITRATE>D>   AB      PHARMACHEMIE               EQ 20MG BASE                            N74858 001  Feb 20, 2003    May  CRLD>A>   AB  +   TEVA PHARMS                EQ 20MG BASE                            N74858 001  Feb 20, 2003    May  CRLD        TECHNETIUM TC-99M SESTAMIBI KIT          INJECTABLE; INJECTION>D>         MIRALUMA>D>       +   BRISTOL MYERS              N/A                                     N19785 003  May 23, 1997    May  DISC>A>         @                            N/A                                     N19785 003  May 23, 1997    May  DISC>A>     TEMSIROLIMUS>A>       SOLUTION; INTRAVENOUS>A>         TORISEL>A>       +   WYETH PHARMS               25MG/ML (25MG/ML)                       N22088 001  May 30, 2007    May  NEWA        TESTOSTERONE          GEL; TRANSDERMAL            TESTOSTERONE>A>   AB      PAR PHARM                  1%                                      N76744 001  May 23, 2007    May  NEWA        TETRACYCLINE HYDROCHLORIDE          FIBER, EXTENDED RELEASE; PERIODONTAL            ACTISITE>D>         @ ALZA                       12.7MG/FIBER                            N50653 001  Mar 25, 1994    May  CAHN>A>         @ ON SITE                    12.7MG/FIBER                            N50653 001  Mar 25, 1994    May  CAHN        THIORIDAZINE HYDROCHLORIDE          CONCENTRATE; ORAL>D>         THIORIDAZINE HYDROCHLORIDE INTENSOL>D>   AA      ROXANE                     30MG/ML                                 N88941 001  Dec 16, 1985    May  DISC>A>         @                            30MG/ML                                 N88941 001  Dec 16, 1985    May  DISC>D>   AA                                 100MG/ML                                N88942 001  Dec 16, 1985    May  DISC>A>         @                            100MG/ML                                N88942 001  Dec 16, 1985    May  DISC        TRANDOLAPRIL; VERAPAMIL HYDROCHLORIDE          TABLET, EXTENDED RELEASE; ORAL            TARKA>D>       +   ABBOTT                     1MG;240MG                               N20591 003  Oct 22, 1996    May  CRLD>A>                                      1MG;240MG                               N20591 003  Oct 22, 1996    May  CRLD>D>       +                              2MG;180MG                               N20591 001  Oct 22, 1996    May  CRLD>A>                                      2MG;180MG                               N20591 001  Oct 22, 1996    May  CRLD>D>       +                              2MG;240MG                               N20591 004  Oct 22, 1996    May  CRLD>A>                                      2MG;240MG                               N20591 004  Oct 22, 1996    May  CRLD        VERAPAMIL HYDROCHLORIDE          CAPSULE, EXTENDED RELEASE; ORAL            VERELAN>D>   AB  +   ELAN DRUG                  120MG                                   N19614 001  May 29, 1990    May  CRLD>A>   AB                                 120MG                                   N19614 001  May 29, 1990    May  CRLD>D>   AB  +                              180MG                                   N19614 003  Jan 09, 1992    May  CRLD>A>   AB                                 180MG                                   N19614 003  Jan 09, 1992    May  CRLD>D>   AB  +                              240MG                                   N19614 002  May 29, 1990    May  CRLD>A>   AB                                 240MG                                   N19614 002  May 29, 1990    May  CRLD        ZICONOTIDE          INJECTABLE; INTRATHECAL            PRIALT>D>       +   ELAN PHARMS                100UGM/1ML(100MG/ML)                    N21060 002  Dec 28, 2004    May  CPOT>A>       +                              100UGM/1ML(100UGM/ML)                   N21060 002  Dec 28, 2004    May  CPOT>D>       +                              500UGM/20ML(25MG/ML)                    N21060 001  Dec 28, 2004    May  CPOT>A>       +                              500UGM/20ML(25UGM/ML)                   N21060 001  Dec 28, 2004    May  CPOT>D>       +                              500UGM/5ML(100MG/ML)                    N21060 004  Dec 28, 2004    May  CPOT>A>       +                              500UGM/5ML(100UGM/ML)                   N21060 004  Dec 28, 2004    May  CPOT        ZIDOVUDINE          CAPSULE; ORAL            ZIDOVUDINE>A>   AB      CIPLA LTD                  100MG                                   N78349 001  May 23, 2007    May  NEWA        ZILEUTON>A>       TABLET, EXTENDED RELEASE; ORAL>A>         ZYFLO CR>A>       +   CRITICAL                   600MG                                   N22052 001  May 30, 2007    May  NEWA        ZOLPIDEM TARTRATE          TABLET; ORAL            ZOLPIDEM TARTRATE>A>   AB      WOCKHARDT                  5MG                                     N78426 001  May 15, 2007    May  NEWA>A>   AB                                 10MG                                    N78426 002  May 15, 2007    May  NEWA

ADDITIONS/DELETIONS FOR OTC DRUG PRODUCT LIST 

        BROMPHENIRAMINE MALEATE; PSEUDOEPHEDRINE HYDROCHLORIDE          TABLET, EXTENDED RELEASE; ORAL            EFIDAC 24 PSEUDOEPHEDRINE HYDROCHLORIDE/BROMPHENIRAMINE MALEATE>D>       +   ALZA                       16MG;240MG                              N19672 001  Mar 29, 1996    May  DISC>A>         @                            16MG;240MG                              N19672 001  Mar 29, 1996    May  DISC        NICOTINE POLACRILEX          GUM, CHEWING; BUCCAL            NICOTINE POLACRILEX>A>           PERRIGO R AND D            EQ 2MG BASE                             N78547 001  May 24, 2007    May  NEWA>A>                                      EQ 4MG BASE                             N78546 001  May 24, 2007    May  NEWA        PSEUDOEPHEDRINE HYDROCHLORIDE          TABLET, EXTENDED RELEASE; ORAL>D>         EFIDAC 24 PSEUDOEPHEDRINE HYDROCHLORIDE>D>       +   ALZA                       240MG                                   N20021 002  Dec 15, 1992    May  CTNA>A>         SUDAFED 24 HOUR>A>       +   ALZA                       240MG                                   N20021 002  Dec 15, 1992    May  CTNA
 

to top arrow

Need An Actisite Attorney?

First Name Last Name Email Address State
Has Your Health Been Negatively Affected?

Please Describe the Injury

Your Friend's Email Address

Your Email Address

Type a Message (optional)


Looking for an Actisite attorney in Washington, DC? Get in touch with one of our Actisite attorneys in Washington, DC now.

 

Close (x)

Looking for an Attorney?


Please type your question:

Close (x)

logo Find Legal Help for Your Actisite Case - Submit Your Information Below

Do you need legal assistance with your Actisite case?
LegalView may be able to help.


Submit your information below for a free, no-cost evaluation.

We'll submit your information to one of our partner firms.
LegalView's partners represent clients throughout the United States, for a very wide range of legal issues. Submit your information now, to see if one of LegalView's partners can help!

* Indicates Required Fields

First name *
Last name *
Email Address *
Phone Number *
()  -

State *
Legal Issue * FDA Drug Database: Actisite Change
Was There an Injury?
Please Describe The Injury

DISCLAIMER and STATEMENT OF NON-CONFIDENTIALITY

By submitting this form, you agree that completing the above is not intended to create an attorney-client relationship.

Disclosure

Legal WebTV Network LLC, LegalView.com, and LegalWebMedia.com are group advertising sponsored by the attorneys identified here. It is not a lawyer referral service. If you submit information on this website [more...]

Legal WebTV Network LLC, LegalView.com, and LegalWebMedia.com are group advertising sponsored by the attorneys identified here. It is not a lawyer referral service. If you submit information on this website, LegalWebMedia.com will submit your information to the law firms that pay for this group advertising and to respond to your requests for information concerning legal services in their assigned local areas. If there is no sponsoring firm in your state, your inquiry will be submitted to one of the sponsoring law firms on a predetermined, rotating basis. If the sponsoring law firm accepts your case, it will associate with licensed attorneys practicing in your state, if required; the sponsoring law firm may also contact other law firms to see if they may be able to assist.

The information provided by the LegalView.com and LegalWebMedia.com websites is for advertising and informational purposes and should not be considered as legal advice from the sponsoring attorneys. The websites contain general information and may not reflect current legal developments, verdicts, or settlements. LegalView.com contains information created by others or supplied through open forums; the sponsoring law firms are not responsible for the accuracy of this information. Any person viewing or receiving information from these websites should not act or refrain from acting on the basis of any such information without first seeking appropriate legal advice from an attorney in your area. Legal WebTV Network, LLC expressly disclaims any liability with respect to actions taken or not taken by the recipient based on any or all of the information or contents contained in these websites.

Any information sent to Legal WebTV Network LLC through this website is done using standard Web encryption techology. LegalView.com will exercise all reasonable care, within technological limits, to protect the confidentiality of any information submitted via Internet e-mail or through this website. By accessing this website, you may be seeking an attorney to represent you or legal advice. However, none of the sponsoring attorneys represent you yet.

The choice of a lawyer is an important decision and should not be based solely upon advertisements.

Any transmission of information, whether via Internet e-mail or through the website, is solely for evaluation purposes by the sponsoring law firms and their associates. The transmission of any information to any attorney sponsoring advertising on LegalView.com or LegalWebMedia.com does not create an attorney-client relationship between the sender and any recipient. An attorney-client relationship can only be created by a written, signed-fee agreement entered into with an attorney. The sponsoring attorneys will treat your information as a confidential communication for the purpose of obtaining legal services or legal advice.

For more information about the sponsoring law firms, please click here.
This form is secure and encrypted. More information about secure forms and your privacy here.